{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T19:28:49Z","timestamp":1790710129920,"version":"4.1.0"},"reference-count":69,"publisher":"Bentham Science Publishers Ltd.","issue":"23","funder":[{"DOI":"10.13039\/501100003141","name":"CONACYT","doi-asserted-by":"publisher","award":["809343"],"award-info":[{"award-number":["809343"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"CONACYT","doi-asserted-by":"publisher","award":["CVU1001930"],"award-info":[{"award-number":["CVU1001930"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"CONACYT","doi-asserted-by":"publisher","award":["1328"],"award-info":[{"award-number":["1328"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Secretar\u00eda de Educaci\u00f3n, Ciencia, Tecnolog\u00eda e Innovaci\u00f3n de la Ciudad de M\u00e9xico","award":["sectei\/160\/2023-sip-2023-re\/053"],"award-info":[{"award-number":["sectei\/160\/2023-sip-2023-re\/053"]}]},{"DOI":"10.13039\/501100003069","name":"Escuela Superior de Medicina(ESM) of the Instituto Polit\u00e9cnico Nacional","doi-asserted-by":"publisher","award":["20240110"],"award-info":[{"award-number":["20240110"]}],"id":[{"id":"10.13039\/501100003069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003069","name":"Escuela Superior de Medicina(ESM) of the Instituto Polit\u00e9cnico Nacional","doi-asserted-by":"publisher","award":["20242806"],"award-info":[{"award-number":["20242806"]}],"id":[{"id":"10.13039\/501100003069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003069","name":"Escuela Superior de Medicina(ESM) of the Instituto Polit\u00e9cnico Nacional","doi-asserted-by":"publisher","award":["20241016"],"award-info":[{"award-number":["20241016"]}],"id":[{"id":"10.13039\/501100003069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003069","name":"Escuela Superior de Medicina(ESM) of the Instituto Polit\u00e9cnico Nacional","doi-asserted-by":"publisher","award":["20241058"],"award-info":[{"award-number":["20241058"]}],"id":[{"id":"10.13039\/501100003069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006087","name":"PAPIIT, DGAPA, UNAM","doi-asserted-by":"publisher","award":["IN-223519"],"award-info":[{"award-number":["IN-223519"]}],"id":[{"id":"10.13039\/501100006087","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006087","name":"PAPIIT, DGAPA, UNAM","doi-asserted-by":"publisher","award":["IN210222"],"award-info":[{"award-number":["IN210222"]}],"id":[{"id":"10.13039\/501100006087","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006087","name":"PAPIIT, DGAPA, UNAM","doi-asserted-by":"publisher","award":["IN226819"],"award-info":[{"award-number":["IN226819"]}],"id":[{"id":"10.13039\/501100006087","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006087","name":"PAPIIT, DGAPA, UNAM","doi-asserted-by":"publisher","award":["IN221123"],"award-info":[{"award-number":["IN221123"]}],"id":[{"id":"10.13039\/501100006087","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CMC"],"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n<jats:title>Background:<\/jats:title>\n<jats:p>Systemic arterial hypertension is a serious chronic health\nproblem caused by multiple factors. It is a major risk factor for Cardiovascular Diseases\n(CVDs), including heart failure, coronary heart disease, and myocardial infarction. Hypertension\ncan be effectively treated with inhibitors of the Angiotensin Converting Enzyme\n(ACE), such as captopril, enalapril, and lisinopril. However, these drugs are associated\nwith significant adverse reactions (e.g., persistent coughing, skin rashes, and angioedema).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Objective:<\/jats:title>\n<jats:p>Considering the recent insights obtained by our group into the antihypertensive\neffect of boroxazolidones, the aim of the current contribution was to design and synthesize\na series of these compounds derived from \u03b1-amino acids and evaluate them (in\nsilico and in vitro) as inhibitors of ACE and acetylcholinesterase (AChE).<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods:<\/jats:title>\n<jats:p>The best candidates were examined for their in vivo antihypertensive activity\nto regulate high blood pressure in male spontaneously hypertensive rats. Although\nboron-containing compounds were once thought to be toxic in any medical context, they\nhave increasingly been used as antibiotics, antiseptics, and antineoplastic agents. BXZHis,\nBXZ-Lys, BXZ-Orn, BXZ-Phe, and BXZ-Pro were selected in silico as promising\nACE and AChE inhibitors. After synthesis, these molecules were tested in vitro as ACE\nand AChE inhibitors, finding that most were effective at micromolar concentrations.\nThe two best candidates, BXZ-Lys and BXZ-His, were evaluated in vivo with spontaneously\nhypertensive rats.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results:<\/jats:title>\n<jats:p>BXZ-Lys significantly decreased systolic, diastolic, and mean blood pressure,\nbeing more potent than a common ACE inhibitor, captopril.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Conclusion:<\/jats:title>\n<jats:p>Future research is required to elucidate the mechanism of action of this antihypertensive\neffect.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/0109298673310296240820070142","type":"journal-article","created":{"date-parts":[[2024,9,2]],"date-time":"2024-09-02T03:47:30Z","timestamp":1725248850000},"page":"4762-4785","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Boroxazolidones: Synthesis, In Silico and In Vitro Evaluation as ACE\/AChE Dual Inhibitors, and In Vivo Testing of Antihypertensive Activity"],"prefix":"10.2174","volume":"32","author":[{"given":"Alina","family":"Barquet-Nieto","sequence":"first","affiliation":[{"name":"Laboratorio de Investigaci\u00f3n en Bioqu\u00edmica, Secci\u00f3n de Estudios de Posgrado e Investigaci\u00f3n, Escuela Superior\nde Medicina del Instituto Polit\u00e9cnico Nacional, Plan de San Luis y D\u00edaz Mir\u00f3n s\/n Casco de Santo\nTom\u00e1s, 11340, Mexico City, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Guadalupe","family":"Trujillo-Ferrara","sequence":"additional","affiliation":[{"name":"Laboratorio de Investigaci\u00f3n en Bioqu\u00edmica, Secci\u00f3n de Estudios de Posgrado e Investigaci\u00f3n, Escuela Superior\nde Medicina del Instituto Polit\u00e9cnico Nacional, Plan de San Luis y D\u00edaz Mir\u00f3n s\/n Casco de Santo\nTom\u00e1s, 11340, Mexico City, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Andrade-Jorge","sequence":"additional","affiliation":[{"name":"Laboratorio de Investigaci\u00f3n en Bioqu\u00edmica, Secci\u00f3n de Estudios de Posgrado e Investigaci\u00f3n, Escuela Superior\nde Medicina del Instituto Polit\u00e9cnico Nacional, Plan de San Luis y D\u00edaz Mir\u00f3n s\/n Casco de Santo\nTom\u00e1s, 11340, Mexico City, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Edith","family":"Rodr\u00edguez-Rodr\u00edguez","sequence":"additional","affiliation":[{"name":"Unidad de Investigaci\u00f3n en Biomedicina y Carrera de Enfermer\u00eda,\nFacultad de Estudios Superiores-Iztacala, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Av. de los Barrios\n1, Los Reyes Iztacala, Tlalnepantla, 54090, Estado de M\u00e9xico, M\u00e9xico"},{"name":"Bioqu\u00edmica Cl\u00ednica, Carrera de\nQu\u00edmico Farmac\u00e9utico Bi\u00f3logo, Facultad de Estudios Superiores Zaragoza, UNAM, Batalla 5 de mayo s\/n\nesquina Fuerte de Loreto, 09230, Mexico City, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itzell Alejandrina","family":"Gallardo-Ort\u00edz","sequence":"additional","affiliation":[{"name":"Unidad de Investigaci\u00f3n en Biomedicina y Carrera de Enfermer\u00eda,\nFacultad de Estudios Superiores-Iztacala, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Av. de los Barrios\n1, Los Reyes Iztacala, Tlalnepantla, 54090, Estado de M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Villalobos- Molina","sequence":"additional","affiliation":[{"name":"Unidad de Investigaci\u00f3n en Biomedicina y Carrera de Enfermer\u00eda,\nFacultad de Estudios Superiores-Iztacala, Universidad Nacional Aut\u00f3noma de M\u00e9xico, Av. de los Barrios\n1, Los Reyes Iztacala, Tlalnepantla, 54090, Estado de M\u00e9xico, M\u00e9xico"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"233","DOI":"10.21149\/8813","volume":"60","author":"Campos-Nonato I.","year":"2018","unstructured":"Campos-Nonato I.; Hern&#xE1;ndez-Barrera L.; Pedroza-Tob&#xED;as A.; Medina C.; Barquera S.; Hypertension in Mexican adults: prevalence, diagnosis and type of treatment. Ensanut MC 2016. Salud Publica Mex  2018,60(3),233-243","journal-title":"Salud Publica Mex"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.jash.2012.11.007","volume":"2013","author":"Harrison D.G.","year":"2013","unstructured":"Harrison D.G.; The mosaic theory revisited: Common molecular mechanisms coordinating diverse organ and cellular events in hypertension. J Am Soc Hypert  2013,2013,68-74","journal-title":"J Am Soc Hypert"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"175","DOI":"10.31403\/rpgo.v64i2075","volume":"64","author":"Wagner Grau P.","year":"2018","unstructured":"Wagner Grau P.; Fisiopatolog&#xED;a de la hipertensi&#xF3;n arterial: nuevos conceptos. Rev Peru Ginecol Obstet  2018,64(2),175-184","journal-title":"Rev Peru Ginecol Obstet"},{"key":"ref=4","first-page":"184","volume":"54","author":"Moncloa A.B.","year":"2015","unstructured":"Moncloa A.B.; San Martin M.G.; Soto A.T.; Fisiopatologia de La hipertensi&#xF3;n arterial. Diagn&#xF3;stico Per&#xFA;  2015,54(4),184-188","journal-title":"Diagn&#xF3;stico Per&#xFA;"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1097\/HCO.0000000000000631","volume":"34","author":"Ventura H.O.","year":"2019","unstructured":"Ventura H.O.; Lavie C.J.; Editorial: Epidemiology and managing aspects of hypertension. Curr Opin Cardiol  2019,34(4),329-330","journal-title":"Curr Opin Cardiol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.rmclc.2015.04.004","volume":"26","author":"Lira C E.U.M.T.","year":"2015","unstructured":"Lira C E.U.M.T.; Impacto de la hipertensi&#xF3;n arterial como factor de riesgo cardiovascular. Rev Med Clin Las Condes  2015,26(2),156-163","journal-title":"Rev Med Clin Las Condes"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"53","DOI":"10.29277\/cardio.34.1.10","volume":"28","author":"Victoria Ramos M.","year":"2019","unstructured":"Victoria Ramos M.; Mar&#xED;a Victoria Ramos D.; Hipertensi&#xF3;n arterial: novedades de las gu&#xED;as 2018 hipertensi&#xF3;n arterial: novedades de las gu&#xED;as 2018 comentario editorial. Rev Urug Cardiol  2019,28,53-60","journal-title":"Rev Urug Cardiol"},{"key":"ref=8","first-page":"36","volume":"113","author":"Alcazar J.M.","year":"2016","unstructured":"Alcazar J.M.; Oliveras A.; Orte L.M.; Jimenez S.; Hipertensi&#xF3;n arterial esencial S.J.;  Nefrolog&#xED;a al D&#xED;a  2016,113(1),36-41","journal-title":"Nefrolog&#xED;a al D&#xED;a"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","volume":"387","author":"Ettehad D.","year":"2016","unstructured":"Ettehad D.; Emdin C.A.; Kiran A.; Anderson S.G.; Callender T.; Emberson J.; Chalmers J.; Rodgers A.; Rahimi K.; Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet  2016,387(10022),957-967","journal-title":"Lancet"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1001\/jamacardio.2017.1421","volume":"2","author":"Bundy J.D.","year":"2017","unstructured":"Bundy J.D.; Li C.; Stuchlik P.; Bu X.; Kelly T.N.; Mills K.T.; He H.; Chen J.; Whelton P.K.; He J.; Systolic blood pressure reduction and risk of cardiovascular disease and mortality. JAMA Cardiol  2017,2(7),775-781","journal-title":"JAMA Cardiol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.phrs.2018.07.006","volume":"2018","author":"Kumar N.","year":"2018","unstructured":"Kumar N.; Yin C.; The anti-inflammatory peptide Ac-SDKP: Synthesis, role in ace inhibition, and its therapeutic potential in hypertension and cardiovascular diseases. Pharmacol Res  2018,2018,268-279","journal-title":"Pharmacol Res"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1016\/j.peptides.2011.09.010","volume":"32","author":"Nguyen Dinh Cat A.","year":"2011","unstructured":"Nguyen Dinh Cat A.; Touyz R.M.; A new look at the renin\u2013angiotensin system\u2014focusing on the vascular system. Peptides  2011,32(10),2141-2150","journal-title":"Peptides"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1097\/00005344-199406242-00003","volume":"24","author":"Falkenhahn M.","year":"1994","unstructured":"Falkenhahn M.; Gohlke P.; Paul M.; Stoll M.; Unger T.; The renin-angiotensin system in the heart and vascular wall: new therapeutic aspects. J Cardiovasc Pharmacol  1994,24(Suppl. 2),S6-S13","journal-title":"J Cardiovasc Pharmacol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/j.yexcr.2012.02.023","volume":"2012","author":"Crowley S.D.","year":"2012","unstructured":"Crowley S.D.; Coffman T.M.; Recent advances involving the renin-angiotensin system. Experim Cell Res  2012,2012,1049-1056","journal-title":"Experim Cell Res"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1124\/pr.118.017129","volume":"71","author":"Arendse L.B.","year":"2019","unstructured":"Arendse L.B.; Danser A.H.J.; Poglitsch M.; Touyz R.M.; Burnett J.C.; Llorens-Cortes C.; Ehlers M.R.; Sturrock E.D.; Novel therapeutic approaches targeting the renin-angiotensin system and associated peptides in hypertension and heart failure. Pharmacol Rev  2019,71(4),539-570","journal-title":"Pharmacol Rev"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1038\/s41569-019-0244-8","volume":"2020","author":"Paz Ocaranza M.","year":"2020","unstructured":"Paz Ocaranza M.; Riquelme J.A.; Garc&#xED;a L.; Jalil J.E.; Chiong M.; Santos R.A.S.; Lavandero S.; Counter-regulatory renin\u2013angiotensin system in cardiovascular disease. Nat Rev Cardiol  2020,2020,116-129","journal-title":"Nat Rev Cardiol"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4103\/phrev.phrev_45_16","volume":"11","author":"Mun\u2019im A.","year":"2017","unstructured":"Mun\u2019im A.; Ahmad I.; Yanuar A.; Mulia K.; Review of angiotensin-converting enzyme inhibitory assay: Rapid method in drug discovery of herbal plants. Pharmacogn Rev  2017,11(21),1-7","journal-title":"Pharmacogn Rev"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"e001010","DOI":"10.1136\/openhrt-2019-001010","volume":"6","author":"Ko D.","year":"2019","unstructured":"Ko D.; Azizi P.; Koh M.; Chong A.; Austin P.; Stukel T.; Jackevicius C.; Comparative effectiveness of ACE inhibitors and angiotensin receptor blockers in patients with prior myocardial infarction. Open Heart  2019,6(1),e001010","journal-title":"Open Heart"},{"key":"ref=19","first-page":"47","volume":"52","author":"Rivera-Jard&#xF3;n F.F.","year":"2009","unstructured":"Rivera-Jard&#xF3;n F.F.; Castro-Moreno P.; Figueroa-Guill&#xE9;n E.S.; Gallardo-Ort&#xED;z I.A.; God&#xED;nez-Hern&#xE1;ndez D.; Ibarra-Barajas M.; Angiotensin I.I.; Angiotensin II augments renal vasoconstriction via AT1 receptors in L-NAME-induced hypertensive rats. Proc West Pharmacol Soc  2009,52,47-49","journal-title":"Proc West Pharmacol Soc"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"3329","DOI":"10.1016\/j.foodchem.2013.06.048","volume":"141","author":"Chen J.","year":"2013","unstructured":"Chen J.; Wang Y.; Ye R.; Wu Y.; Xia W.; Comparison of analytical methods to assay inhibitors of angiotensin I- converting enzyme. Food Chem  2013,141(4),3329-3334","journal-title":"Food Chem"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.ahj.2003.10.034","volume":"147","author":"Black H.R.","year":"2004","unstructured":"Black H.R.; Evolving role of aldosterone blockers alone and in combination with angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers in hypertension management: a review of mechanistic and clinical data. Am Heart J  2004,147(4),564-572","journal-title":"Am Heart J"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.3390\/md8041080","volume":"8","author":"Wijesekara I.","year":"2010","unstructured":"Wijesekara I.; Kim S.K.; Angiotensin-I-converting enzyme (ACE) inhibitors from marine resources: prospects in the pharmaceutical industry. Mar Drugs  2010,8(4),1080-1093","journal-title":"Mar Drugs"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.jacc.2018.01.058","volume":"2010","author":"Messerli F. H.","year":"2018","unstructured":"Messerli F. H.; Bangalore S.; Bavishi C.; Rimoldi S. F.; Angiotensin-converting enzyme inhibitors in hypertension: to use or not to use? J Am CollCardiol  2018,2010,1080-1093","journal-title":"J Am CollCardiol"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1093\/ajh\/hpv017","volume":"28","author":"Lataro R.M.","year":"2015","unstructured":"Lataro R.M.; Silva C.A.A.; Tef&#xE9;-Silva C.; Prado C.M.; Salgado H.C.; Acetylcholinesterase inhibition attenuates the development of hypertension and inflammation in spontaneously hypertensive rats. Am J Hypertens  2015,28(10),1201-1208","journal-title":"Am J Hypertens"},{"key":"ref=25","first-page":"365","volume":"54","author":"Agrawal N.","year":"2016","unstructured":"Agrawal N.; Akella A.; Captopril augments acetylcholine-induced bronchial smooth muscle contractions in vitro viakinin-dependent mechanisms. Indian J Exp Biol  2016,54(6),365-369","journal-title":"Indian J Exp Biol"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.cjca.2019.02.003","volume":"35","author":"Alves-Lopes R.","year":"2019","unstructured":"Alves-Lopes R.; Neves K.B.; Touyz R.M.; Muscarinic receptor type-3 in hypertension and cholinergic-adrenergic crosstalk: Genetic insights and potential for new antihypertensive targets. Can J Cardiol  2019,35(5),555-557","journal-title":"Can J Cardiol"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1152\/physiolgenomics.00062.2017","volume":"50","author":"Saternos H.C.","year":"2018","unstructured":"Saternos H.C.; Almarghalani D.A.; Gibson H.M.; Meqdad M.A.; Antypas R.B.; Lingireddy A.; AbouAlaiwi W.A.; Distribution and function of the muscarinic receptor subtypes in the cardiovascular system. Physiol Genomics  2018,50(1),1-9","journal-title":"Physiol Genomics"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"593682","DOI":"10.3389\/fphar.2021.593682","volume":"12","author":"Wu S.","year":"2021","unstructured":"Wu S.; Shi Z.; Wang X.; Ren F.; Xie Z.; Lei L.; Chen P.; Activation of the cholinergic anti-inflammatory pathway attenuated angiotension II-dependent hypertension and renal injury. Front Pharmacol  2021,12,593682","journal-title":"Front Pharmacol"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1134\/S1068162023010211","volume":"49","author":"Osipov A.V.","year":"2023","unstructured":"Osipov A.V.; Averin A.S.; Shaykhutdinova E.R.; Dyachenko I.A.; Tsetlin V.I.; Utkin Y.N.; The regulation of the cardiovascular system. Russian J Bioorg Chem  2023,49,1-18","journal-title":"Russian J Bioorg Chem"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"117915","DOI":"10.1016\/j.lfs.2020.117915","volume":"256","author":"Cavalcante G.L.","year":"2020","unstructured":"Cavalcante G.L.; Ferreira F.N.; da Silva M.T.B.; Soriano R.N.; Filho A.L.M.M.; Arcanjo D.D.R.; Sabino J.P.J.; Acetylcholinesterase inhibition prevents alterations in cardiovascular autonomic control and gastric motility in L-NAME-induced hypertensive rats. Life Sci  2020,256,117915","journal-title":"Life Sci"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/ajh\/hpz036","volume":"32","author":"Lataro R.M.","year":"2019","unstructured":"Lataro R.M.; Silva M.A.B.; Mestriner F.L.; Cau S.B.A.; Tostes R.C.A.; Salgado H.C.; Chronic treatment with acetylcholinesterase inhibitors attenuates vascular dysfunction in spontaneously hypertensive rats. Am J Hypertens  2019,32(6),579-587","journal-title":"Am J Hypertens"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1136\/jnnp.74.9.1187","volume":"2003","author":"Schondorf R.","year":"2003","unstructured":"Schondorf R.; Acetylcholinesterase inhibition in the treatment of hypotension. J Neurol Neurosurg Psych  2003,2003,1187","journal-title":"J Neurol Neurosurg Psych"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/BF01728352","volume":"60","author":"Walter U.","year":"1982","unstructured":"Walter U.; Studies on erythrocyte acetylcholinesterase in essential hypertension. Klin Wochenschr  1982,60(16),853-857","journal-title":"Klin Wochenschr"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/BF01249194","volume":"49","author":"Martins Silva J.","year":"1980","unstructured":"Martins Silva J.; Gorj&#xE3;o Clara J.; Erythrocyte acetylcholinesterase in essential hypertension hypertension view project long term consequences o pregnancy hypertensive diseases (preclampsia, gestational hypertension) in the women and its childhood view project. J Neural Transm  1980,49,127-132","journal-title":"J Neural Transm"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.autneu.2015.09.002","volume":"193","author":"Blanco J.H.D.","year":"2015","unstructured":"Blanco J.H.D.; Gastaldi A.C.; Gardim C.B.; Araujo J.E.; Sim&#xF5;es M.V.; Oliveira L.F.L.; Carvalho E.E.V.; Souza H.C.D.; Chronic cholinergic stimulation promotes changes in cardiovascular autonomic control in spontaneously hypertensive rats. Auton Neurosci  2015,193,97-103","journal-title":"Auton Neurosci"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"e13663","DOI":"10.1111\/apha.13663","volume":"232","author":"Cavalcante G.L.","year":"2021","unstructured":"Cavalcante G.L.; Brognara F.; Oliveira L.V.C.; Lataro R.M.; Durand M.T.; de Oliveira A.P.; da N&#xF3;brega A.C.L.; Salgado H.C.; Sabino J.P.J.; Benefits of pharmacological and electrical cholinergic stimulation in hypertension and heart failure. Acta Physiol (Oxf)  2021,232(3),e13663","journal-title":"Acta Physiol (Oxf)"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"176526","DOI":"10.1016\/j.ejphar.2024.176526","volume":"971","author":"Bencze M.","year":"2024","unstructured":"Bencze M.; Boro\u0161 A.; Behuliak M.; Vav\u0159&#xED;nov&#xE1; A.; Van&#x11B;&#x10D;kov&#xE1; I.; Zicha J.; Changes in cardiovascular autonomic control induced by chronic inhibition of acetylcholinesterase during pyridostigmine or donepezil treatment of spontaneously hypertensive rats. Eur J Pharmacol  2024,971,176526","journal-title":"Eur J Pharmacol"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"298","DOI":"10.2174\/1385272821666170427124336","volume":"22","author":"Andrade-Jorge E.","year":"2018","unstructured":"Andrade-Jorge E.; Garcia-Avila A.K.; Ocampo-Nestor A.L.; Trujillo-Ferrara J.G.; Soriano-Ursua M.A.; Advances of bioinformatics applied to development and evaluation of boron-containing compounds. Curr Org Chem  2018,22(3),298-306","journal-title":"Curr Org Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5528\/wjtm.v6.i1.1","volume":"6","author":"Garc&#xED;a-&#xC1;vila A.K.","year":"2017","unstructured":"Garc&#xED;a-&#xC1;vila A.K.; Farf&#xE1;n-Garc&#xED;a E.D.; Guevara-Salazar J.A.; Trujillo-Ferrara J.G.; Soriano-Urs&#xFA;a M.A.; Scope of translational medicine in developing boron-containing compounds for therapeutics. World J Transl Med  2017,6(1),1","journal-title":"World J Transl Med"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/13543776.2017.1252750","volume":"27","author":"Ocampo-N&#xE9;stor A. L.","year":"2017","unstructured":"Ocampo-N&#xE9;stor A. L.; Trujillo-Ferrara J. G.; Abad-Garc&#xED;a A.; Reyes-L&#xF3;pez C.; Geninatti-Crich S.; Soriano-Urs&#xFA;a M. A.; Boron\u2019s journey: Advances in the study and application of pharmacokinetics. expert opinion on therapeutic patents. Tayl Franc  2017,27(2),203-215","journal-title":"Tayl Franc"},{"key":"ref=41","doi-asserted-by":"publisher","DOI":"10.2174\/0929867325666180926150403","volume":"25","author":"Garcia A.A.","year":"2018","unstructured":"Garcia A.A.; Rayevski A.; Andrade-Jorge E.; Trujillo- Ferrara J.G.; Structural and biological overview of boron- containing amino acids in the medicinal chemistry field. Curr Med Chem  2018,25","journal-title":"Curr Med Chem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1002\/chir.20594","volume":"23","author":"Araujo-Alvarez J.M.","year":"2011","unstructured":"Araujo-Alvarez J.M.; Trujillo-Ferrara J.G.; Ponce-Franco D.; Correa-Basurto J.; Delgado A.; Querejeta E.; (+)-( S )-trujillon, (+)-( S )-4-(2,2-diphenyl-1,3,2-oxazabolidin-5-oxo)propionic acid, a novel glutamatergic analog, modifies the activity of globus pallidus neurons by selective NMDA receptor activation. Chirality  2011,23(6),429-437","journal-title":"Chirality"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"5005","DOI":"10.2174\/0929867326666190327154954","volume":"26","author":"Soriano-Urs&#xFA;a M.A.","year":"2019","unstructured":"Soriano-Urs&#xFA;a M.A.; Farf&#xE1;n-Garc&#xED;a E.D.; Geninatti-Crich S.; Turning fear of boron toxicity into boron-containing drug design. Curr Med Chem  2019,26(26),5005-5018","journal-title":"Curr Med Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/j.toxlet.2016.06.018","author":"Farf&#xE1;n-Garc&#xED;a E.D.","year":"2016","unstructured":"Farf&#xE1;n-Garc&#xED;a E.D.; Castillo-Mendieta N.T.; Cipr&#xE9;s-Flores F.J.; Padilla-Mart&#xED;nez I.I.; Trujillo-Ferrara J.G.; Soriano-Urs&#xFA;a M.A.;  Current Data Regarding the Structure- Toxicity Relationship of Boron-Containing Compounds Toxicology Letters  2016,115-125","journal-title":"Current Data Regarding the Structure- Toxicity Relationship of Boron-Containing Compounds Toxicology Letters"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jtemb.2018.06.003","volume":"2018","author":"Donoiu I.","year":"2018","unstructured":"Donoiu I.; Militaru C.; Obleag\u0103 O.; Hunter J.M.; Neam\u0163u J.; Bi\u0163\u0103 A.; Scorei I.R.; Rogoveanu O.C.; Effects of boron-containing compounds on cardiovascular disease risk factors \u2013 a review. J Trace Element Med Biol  2018,2018,47-56","journal-title":"J Trace Element Med Biol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1517\/13543776.2014.881472","volume":"24","author":"Soriano-Urs&#xFA;a M.A.","year":"2014","unstructured":"Soriano-Urs&#xFA;a M.A.; Das B.C.; Trujillo-Ferrara J.G.; Boron-containing compounds: chemico-biological properties and expanding medicinal potential in prevention, diagnosis and therapy. Expert Opin Ther Pat  2014,24(5),485-500","journal-title":"Expert Opin Ther Pat"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.jtemb.2018.08.009","volume":"50","author":"L&#xF3;pez-Cabrera Y.","year":"2018","unstructured":"L&#xF3;pez-Cabrera Y.; Castillo-Garc&#xED;a E.L.; Altamirano-Espino J.A.; P&#xE9;rez-Capistran T.; Farf&#xE1;n-Garc&#xED;a E.D.; Trujillo-Ferrara J.G.; Soriano-Urs&#xFA;a M.A.; Profile of three boron-containing compounds on the body weight, metabolism and inflammatory markers of diabetic rats. J Trace Elem Med Biol  2018,50,424-429","journal-title":"J Trace Elem Med Biol"},{"key":"ref=48","author":"Valdez IR.","year":"2020","unstructured":"Valdez IR.; Santiago-Quintana JM.; Rosalez M.; Farfan E.; Soriano-Ursua MA.; Theoretical evaluation of bortezomib and other boron-containing compounds as inhibitors of SARS-CoV-2 main protease. ChemRxiv  2020","journal-title":"ChemRxiv"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1016\/j.bmc.2011.11.054","volume":"20","author":"Soriano-Urs&#xFA;a M.A.","year":"2012","unstructured":"Soriano-Urs&#xFA;a M.A.; McNaught-Flores D.A.; Nieto-Alamilla G.; Segura-Cabrera A.; Correa-Basurto J.; Arias-Monta&#xF1;o J.A.; Trujillo-Ferrara J.G.; Cell-based and in-silico studies on the high intrinsic activity of two boron- containing salbutamol derivatives at the human\u03b22-adrenoceptor. Bioorg Med Chem  2012,20(2),933-941","journal-title":"Bioorg Med Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.neuro.2017.06.004","volume":"62","author":"P&#xE9;rez-Rodr&#xED;guez M.","year":"2017","unstructured":"P&#xE9;rez-Rodr&#xED;guez M.; Garc&#xED;a-Mendoza E.; Farf&#xE1;n-Garc&#xED;a E.D.; Das B.C.; Cipr&#xE9;s-Flores F.J.; Trujillo-Ferrara J.G.; Tamay-Cach F.; Soriano-Urs&#xFA;a M.A.; Not all boronic acids with a five-membered cycle induce tremor, neuronal damage and decreased dopamine. Neurotoxicology  2017,62,92-99","journal-title":"Neurotoxicology"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1031","DOI":"10.2174\/138955711797247743","volume":"11","author":"Soriano-Urs&#xFA;a M.A.","year":"2011","unstructured":"Soriano-Urs&#xFA;a M.A.; Mancilla-Percino T.; Correa-Basurto J.; Querejeta E.; Trujillo-Ferrara J.G.; Give boron a chance: boron containing compounds reach ionotropic and metabotropic transmembrane receptors. Mini Rev Med Chem  2011,11(12),1031-1038","journal-title":"Mini Rev Med Chem"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"4156","DOI":"10.1021\/cr608202m","volume":"2012","author":"Smoum R.","year":"2012","unstructured":"Smoum R.; Rubinstein A.; Dembitsky V.M.; Srebnik M.; Boron containing compounds as protease inhibitors. Chemical reviews. Am Chem Soc  2012,2012,4156-4220","journal-title":"Am Chem Soc"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.5528\/wjtm.v7.i1.1","volume":"7","author":"Farf&#xE1;n-Garc&#xED;a E.D.","year":"2018","unstructured":"Farf&#xE1;n-Garc&#xED;a E.D.; Castillo-Garc&#xED;a E.L.; Soriano-Urs&#xFA;a M.A.; More than boric acid: Increasing relevance of boron in medicine. World J Transl Med  2018,7(1),1-4","journal-title":"World J Transl Med"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1016\/j.bmcl.2014.12.077","volume":"25","author":"Soriano-Urs&#xFA;a M.A.","year":"2015","unstructured":"Soriano-Urs&#xFA;a M.A.; Arias-Monta&#xF1;o J.A.; Correa-Basurto J.; Hern&#xE1;ndez-Mart&#xED;nez C.F.; L&#xF3;pez-Cabrera Y.; Castillo-Hern&#xE1;ndez M.C.; Padilla-Mart&#xED;nez I.I.; Trujillo-Ferrara J.G.; Insights on the role of boron containing moieties in the design of new potent and efficient agonists targeting the\u03b22 adrenoceptor. Bioorg Med Chem Lett  2015,25(4),820-825","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.brainres.2014.08.015","volume":"1583","author":"Roda E.","year":"2014","unstructured":"Roda E.; Nion S.; Bernocchi G.; Coccini T.; Blood\u2013brain barrier (BBB) toxicity and permeability assessment after L-(4-10Boronophenyl)alanine, a conventional B-containing drug for boron neutron capture therapy, using an in vitro BBB model. Brain Res  2014,1583(1),34-44","journal-title":"Brain Res"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.3791\/1291","author":"Daugherty A.","year":"2009","unstructured":"Daugherty A.; Rateri D.; Hong L.; Balakrishnan A.; Measuring blood pressure in mice using volume pressure recording, a tail-cuff method. J Vis Exp  2009(27),1291","journal-title":"J Vis Exp"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1756","DOI":"10.1248\/bpb.29.1756","volume":"29","author":"Kubota Y.","year":"2006","unstructured":"Kubota Y.; Umegaki K.; Kagota S.; Tanaka N.; Nakamura K.; Kunitomo M.; Shinozuka K.; Evaluation of blood pressure measured by tail-cuff methods (without heating) in spontaneously hypertensive rats. Biol Pharm Bull  2006,29(8),1756-1758","journal-title":"Biol Pharm Bull"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1590\/S0100-879X2010007500023","volume":"43","author":"Rocha W.A.","year":"2010","unstructured":"Rocha W.A.; Lunz W.; Baldo M.P.; Pimentel E.B.; Dantas E.M.; Rodrigues S.L.; Mill J.G.; Kinetics of cardiac and vascular remodeling by spontaneously hypertensive rats after discontinuation of long-term captopril treatment. Braz J Med Biol Res  2010,43(4),390-396","journal-title":"Braz J Med Biol Res"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"551","DOI":"10.1038\/nature01370","volume":"421","author":"Natesh R.","year":"2003","unstructured":"Natesh R.; Schwager S.L.U.; Sturrock E.D.; Acharya K.R.; Crystal structure of the human angiotensin-converting enzyme\u2013lisinopril complex. Nature  2003,421(6922),551-554","journal-title":"Nature"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/gb-2003-4-8-225","volume":"4","author":"Riordan J.F.","year":"2003","unstructured":"Riordan J.F.; Angiotensin-I-converting enzyme and its relatives. Genome Biol  2003,4(8),225","journal-title":"Genome Biol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1046\/j.1523-1755.1998.00924.x","volume":"Vol. 53","author":"Va\u0161k&#x16F; A.","year":"1998","unstructured":"Va\u0161k&#x16F; A.; Sou&#x10D;ek M.; Znojil V.; \u0158ih&#xE1;&#x10D;ek I.; Tsch&#xF6;plov&#xE1; S.; St\u0159elcov&#xE1; L.; C&#xED;dl K.; Bla&#x17E;kov&#xE1; M.; H&#xE1;jek D.; Holl&#xE1; L.; V&#xE1;cha J.;  Kidney International  1998,Vol. 53,1479-1482","journal-title":"Kidney International"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/j.foodchem.2005.06.006","volume":"97","author":"Sentandreu M.","year":"2006","unstructured":"Sentandreu M.; Toldr&#xE1; F.; A rapid, simple and sensitive fluorescence method for the assay of angiotensin-I converting enzyme. Food Chem  2006,97(3),546-554","journal-title":"Food Chem"},{"key":"ref=63","doi-asserted-by":"publisher","DOI":"10.1016\/B978-008055232-3.60552-5","author":"Hooper N.M.","year":"2007","unstructured":"Hooper N.M.; Angiotensin I-converting enzyme (ACE). xPharm: The comprehensive pharmacology reference  2007","journal-title":"xPharm: The comprehensive pharmacology reference"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1161\/01.RES.0000081593.33848.FC","volume":"93","author":"Georgiadis D.","year":"2003","unstructured":"Georgiadis D.; Beau F.; Czarny B.; Cotton J.; Yiotakis A.; Dive V.; Roles of the two active sites of somatic angiotensin-converting enzyme in the cleavage of angiotensin I and bradykinin: insights from selective inhibitors. Circ Res  2003,93(2),148-154","journal-title":"Circ Res"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/hr.2012.2","volume":"35","author":"Hale T.M.","year":"2012","unstructured":"Hale T.M.; Robertson S.J.; Burns K.D.; DeBlois D.; Short-term ACE inhibition confers long-term protection against target organ damage. Hypert Res  2012,35(6),604-610","journal-title":"Hypert Res"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"10615","DOI":"10.1021\/jf072307o","volume":"55","author":"Miguel M.","year":"2007","unstructured":"Miguel M.; Manso M.; Aleixandre A.; Alonso M.J.; Salaices M.; L&#xF3;pez-Fandi&#xF1;o R.; Vascular effects, angiotensin I-converting enzyme (ACE)-inhibitory activity, and antihypertensive properties of peptides derived from egg white. J Agric Food Chem  2007,55(26),10615-10621","journal-title":"J Agric Food Chem"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1079\/BJN20051570","volume":"94","author":"Miguel M.","year":"2005","unstructured":"Miguel M.; L&#xF3;pez-Fandi&#xF1;o R.; Ramos M.; Aleixandre A.; Short-term effect of egg-white hydrolysate products on the arterial blood pressure of hypertensive rats. Br J Nutr  2005,94(5),731-737","journal-title":"Br J Nutr"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.3390\/biomedicines10123059","volume":"10","author":"Rassler B.","year":"2022","unstructured":"Rassler B.; Hawlitschek C.; Brendel J.; Zimmer H. G.; How do young and old spontaneously hypertensive rats respond to antihypertensive therapy? comparative studies on the effects of combined captopril and nifedipine treatment. Biomedicines  2022,10(12),3059","journal-title":"Biomedicines"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1016\/j.sjbs.2021.08.093","volume":"29","author":"Hawlitschek C.","year":"2022","unstructured":"Hawlitschek C.; Brendel J.; Gabriel P.; Schierle K.; Salameh A.; Zimmer H.G.; Rassler B.; Antihypertensive and cardioprotective effects of different monotherapies and combination therapies in young spontaneously hypertensive rats \u2013 a pilot study. Saudi J Biol Sci  2022,29(1),339-345","journal-title":"Saudi J Biol Sci"}],"container-title":["Current Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673310296240820070142","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/233539\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0109298673310296240820070142","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T12:01:29Z","timestamp":1755000089000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/233539\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":69,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0109298673310296240820070142","relation":{},"ISSN":["0929-8673"],"issn-type":[{"value":"0929-8673","type":"print"}],"subject":[],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-04-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-19","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-06-25","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}